Alterity Therapeutics Limited
ATH
Pozycja w akcjach
#26251
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Cena akcji
$0.17914134
Ostatnia synchronizacja: 2026-10-21
Kapitalizacja rynkowa
$39.14M
Zmiana (1 dzień)
-0.39%
Zmiana (1 rok)
-48.82%
Kraj
AU
Handel Alterity Therapeutics Limited (ATH)
Kategoria
Healthcare
Historia ceny akcji dla Alterity Therapeutics Limited (ATH)
Najwyższa cena zamknięcia: $0.33 dnia 2026-10-01
Najniższa cena zamknięcia: $13.50 dnia 2012-09-01
Najniższa cena zamknięcia: $13.50 dnia 2012-09-01
Historia cen akcji firmy Alterity Therapeutics Limited od 2012 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | -12.13% |
| 2025 | 75.00% |
| 2024 | -18.18% |
| 2023 | -37.61% |
| 2022 | -59.70% |
| 2021 | -39.12% |
| 2020 | 63.99% |
| 2019 | -39.67% |
| 2018 | -32.87% |
| 2017 | 8.20% |
| 2016 | -48.69% |
| 2015 | -55.45% |
| 2014 | -69.99% |
| 2013 | 162.07% |
| 2012 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $136.63 | -4.62% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
